Recurrent Glioma: Clinical Trials

4 trials for Recurrent Glioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 not yet recruiting, 1 terminated. 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Active not recruiting 2, Not yet recruiting 1, Terminated 1

Follow Recurrent Glioma: new trials by email Literature Review of Recurrent Glioma trials Research Report on Recurrent Glioma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
[F-18]MeFAMP PET - Healthy Volunteers, Recurrent Glioma
Early Phase 1Not yet recruitingUniversity of Alabama at Birmingham282027-04-012026-08-20
Niraparib In Recurrent IDH 1/2 Gliomas
Niraparib, Resection/Treatment with Niraparib - Low-grade Glioma, IDH2 Gene Mutation
Early Phase 1Active not recruitingMassachusetts General Hospital162023-05-182026-07-24
Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma
Biospecimen Collection, Diagnostic Imaging, Magnetic Resonance Imaging - Glioma, Malignant Glioma
Early Phase 1Active not recruitingJonsson Comprehensive Cancer Center362021-09-012026-10-20
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases
Best Practice, Ketoconazole - Anatomic Stage IV Breast Cancer AJCC v8, Astrocytoma
Early Phase 1TerminatedWake Forest University Health Sciences152019-03-132026-07-31

Narrower conditions

Glioma (4)  ·  Astrocytoma (1)  ·  Oligodendroglioma (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Germ Cell and Embryonal (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Neoplasms, Neuroepithelial (4)  ·  Neuroectodermal Tumors (4)

Interventions

Ketoconazole (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Practice Guidelines as Topic (1)  ·  Standard of Care (1)  ·  Therapeutics (1)  ·  X-Rays (1)  ·  niraparib (1)

Sponsors

Jonsson Comprehensive Cancer Center (1)  ·  Massachusetts General Hospital (1)  ·  University of Alabama at Birmingham (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (4)

Top investigators

Benjamin M Ellingson (1)  ·  Isabel Arrillaga-Romany, MD, Phd (1)  ·  Jonathan McConathy, MD, PhD (1)  ·  Roy Strowd, MD (1)

NIH funding

P30CA012197 (1)